Primary Versus Secondary NAFLD: Perspective on Advanced Fibrosis [0.03%]
原发性和继发性非酒精性脂肪肝病：针对晚期纤维化患者的视角
Divya Shetty,Anjali Amarapurkar,Akash Shukla
Divya Shetty
Background: The presence of macrovesicular steatosis on liver biopsy is the commonest histopathological finding. Nonalcoholic fatty liver disease (NAFLD) is the presence of ≥5% macrovesicular steatosis without significan...
Learning Gains of Liver Resection and Transplantation Workshop on Genelyn® Embalmed Human Cadavers: Surgical Gastroenterologists' Perceptions [0.03%]
肝切除及肝移植尸体解剖模拟操作研讨会的学习效果-胃肠外科医师的视角
Sajja Srinivasa Siva Naga Rajasekhar,Vishwakumar Dinesh Kumar,Gnanasekaran Senthil et al.
Sajja Srinivasa Siva Naga Rajasekhar et al.
Background: In the light of increased requirement for liver transplantation procedures, it is pertinent to develop bankable human expertise in the areas of liver resection and anastomoses. The alternative simulator source...
Nonalcoholic Fatty Liver in Lean Individuals: Clinicobiochemical Correlates of Histopathology in 157 Liver Biopsies from Healthy Liver Donors [0.03%]
肝脏健康捐赠者中的非酒精性脂肪肝的临床生化指标及157例肝脏活检的病理相关性研究
Narendra S Choudhary,Neeraj Saraf,Sanjiv Saigal et al.
Narendra S Choudhary et al.
Background: Generally diagnosis of non-alcoholic fatty disease is made on imaging, however, mild steatosis is difficult to diagnose on imaging. Liver biopsy is the procedure of choice but is not carried out as it is an in...
The Clinical Impact of Cirrhosis on the Hospital Outcomes of Patients Admitted With Influenza Infection: Propensity Score Matched Analysis of 2011-2017 US Hospital Data [0.03%]
基于2011年至2017年美国住院资料的倾向匹配分析：肝硬化对流感病毒感染住院患者预后的影响
David U Lee,Gregory H Fan,David J Hastie et al.
David U Lee et al.
Background/objectives: Patients with cirrhosis have liver-related immune dysfunction that potentially predisposes the patients to increased influenza infection risk. Our study evaluates this cross-sectional relationship u...
Naaventhan Palaniyappan,Guruprasad P Aithal
Naaventhan Palaniyappan
Madhumita Premkumar,Anil C Anand
Madhumita Premkumar
Remarks on "Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series" [0.03%]
关于《中药免疫增强剂引起肝损伤的大流行病学研究——一系列病例》的评论
Rohit Sharma,Pradeep K Prajapati
Rohit Sharma
Tinospora Cordifolia (Giloy) and Autoimmune-like Liver Injury - A Classic Case of Primum Non Nocere, "First, Do No Harm" [0.03%]
假借自身免疫性肝损伤的穿心莲内酯乳膏导致的肝损伤——“首先，不要造成伤害”的典型案例分析
Cyriac A Philips,Libin Abraham;Mission for Ethics and Science in Health Care (MESH)
Cyriac A Philips
Herbal Immunity Booster-Associated Liver Injury During COVID-19 Pandemic and Aflatoxins [0.03%]
新冠肺炎大流行期间与中药免疫增强药相关性肝损伤及黄曲霉毒素的影响
Ravishankar M Vamadevaiah,Prasanna K Santhekadur
Ravishankar M Vamadevaiah
Liver Transplant Society of India Guidelines for Liver Transplant During COVID-19 times [0.03%]
印度肝移植协会COVID-19时期肝移植指南
Subash Gupta,Surendran Sudhindran,Neeraj Saraf et al.
Subash Gupta et al.
Coronavirus disease-2019 (COVID-19) pandemic has affected liver transplantation in many ways. There is risk of infection to the transplant recipients; and COVID-19 is associated with significant risk of mortality in patients on wait list. T...